Does CABOTEGRAVIR Cause Injection site nodule? 178 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 178 reports of Injection site nodule have been filed in association with CABOTEGRAVIR (Apretude). This represents 2.1% of all adverse event reports for CABOTEGRAVIR.
178
Reports of Injection site nodule with CABOTEGRAVIR
2.1%
of all CABOTEGRAVIR reports
0
Deaths
0
Hospitalizations
How Dangerous Is Injection site nodule From CABOTEGRAVIR?
Of the 178 reports.
Is Injection site nodule Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CABOTEGRAVIR. However, 178 reports have been filed with the FAERS database.
What Other Side Effects Does CABOTEGRAVIR Cause?
Product dose omission issue (1,121)
Off label use (1,049)
Injection site pain (924)
Viral load increased (452)
Pain (399)
Virologic failure (275)
Pathogen resistance (270)
Pyrexia (255)
Product use in unapproved therapeutic environment (234)
Inappropriate schedule of product administration (228)
What Other Drugs Cause Injection site nodule?
EXENATIDE (2,167)
HYDROXYPROGESTERONE CAPROATE (425)
ADALIMUMAB (364)
PALIPERIDONE (313)
DUPILUMAB (271)
BYDUREON (241)
ETANERCEPT (215)
NALTREXONE (154)
CABOTEGRAVIR\RILPIVIRINE (153)
RILPIVIRINE (150)
Which CABOTEGRAVIR Alternatives Have Lower Injection site nodule Risk?
CABOTEGRAVIR vs CABOTEGRAVIR\RILPIVIRINE
CABOTEGRAVIR vs CABOZANTINIB
CABOTEGRAVIR vs CABOZANTINIB S-MALATE
CABOTEGRAVIR vs CAFFEINE
CABOTEGRAVIR vs CALASPARGASE PEGOL